Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. (TARS) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 279 transactions totaling $61.9M, demonstrating a bearish sentiment with -$28.9M in net insider flow. The most recent transaction on Dec 24, 2025 involved a sale of 557 shares valued at $46.5K.
TARS Insider Activity Summary
Who Is Buying TARS Stock?
No significant insider buying has been recorded for TARS in the recent period.
Who Is Selling TARS Stock?
No significant insider selling has been recorded for TARS in the recent period.
Is Tarsus Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TARS is bearish with an Insider Alignment Score of 27/100 and a net flow of -$28.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
TARS Frequently Asked Questions
Understanding TARS Insider Activity
Insider trading at Tarsus Pharmaceuticals, Inc. (TARS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading TARS stock, having executed 279 transactions in the past 90 days. The most active insider is Investments, Lp Rtw (Executive), who has made 1 transactions totaling $13.5M.
Related Tools
Track Tarsus Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at TARS file new Form 4 transactions